Evening primrose oil dosage recommendations
Pro Research Analysisby 
Searched over 200M research papers
Evening Primrose Oil Dosage Recommendations for Atopic Dermatitis
Research in children and adolescents with atopic dermatitis has explored two oral evening primrose oil dosages: 160 mg daily and 320 mg twice daily, both administered for 8 weeks. Both dosages led to improvements in eczema severity, but the higher dose (320 mg twice daily) showed greater improvements in clinical symptoms and serum fatty acid levels. Importantly, no side effects were reported for either dosage during the study period, suggesting both are generally well tolerated for short-term use in this population .
Evening Primrose Oil Dosage for Acne Vulgaris (with Isotretinoin)
In a study involving patients treated for acne vulgaris, evening primrose oil was given at a dosage of 4 × 510 mg per day (totaling 2,040 mg daily) for 9 months alongside isotretinoin. This regimen was associated with beneficial effects on blood lipid profiles and liver enzyme activity, with no significant impact on dietary intake. However, the study notes that longer-term research is needed to confirm safety and efficacy for this dosage .
Evening Primrose Oil Dosage for Cyclical Mastalgia
For women experiencing cyclical mastalgia (breast pain), a daily oral dose of 3,000 mg of evening primrose oil for six months was evaluated. This dosage, either alone or combined with vitamin E, was associated with a reduction in breast pain severity. The study suggests that 3,000 mg per day may be effective for this condition .
Evening Primrose Oil Dosage for Cervical Ripening
In the context of cervical ripening prior to labor induction in post-term pregnancies, a single vaginal dose of 1,000 mg evening primrose oil was used. This intervention improved cervical readiness for labor without reported adverse effects, indicating that a one-time 1,000 mg vaginal dose may be beneficial in this specific scenario .
Evening Primrose Oil Dosage in Animal Studies
Animal research has used a dosage of 1.5 ml/kg body weight per day of evening primrose oil for 14 days to study its antioxidative effects. While this provides insight into potential benefits, direct translation of this dosage to humans is not recommended without further clinical evidence .
Conclusion
Evening primrose oil dosages vary depending on the condition being treated:
- For atopic dermatitis: 160 mg daily or 320 mg twice daily (oral) for 8 weeks .
- For acne vulgaris (with isotretinoin): 2,040 mg daily (oral) for 9 months .
- For cyclical mastalgia: 3,000 mg daily (oral) for 6 months .
- For cervical ripening: 1,000 mg (vaginal, single dose) .
These studies report good tolerability at the tested dosages, but longer-term safety and optimal dosing require further research. Always consult a healthcare provider before starting evening primrose oil supplementation.
Sources and full results
Most relevant research papers on this topic
Dose-Dependent Effects of Evening Primrose Oil in Children and Adolescents with Atopic Dermatitis
Evening primrose oil treatment with 320 mg twice daily for 8 weeks is equally effective as 160 mg daily for treating atopic dermatitis, with greater improvement in eczema severity scores.
Effect of Evening Primrose Oil Supplementation on Biochemical Parameters and Nutrition of Patients Treated with Isotretinoin for Acne Vulgaris: A Randomized Double-Blind Trial
Evening primrose oil supplementation improves lipid profiles and reduces transaminase activity in acne patients treated with isotretinoin, but does not affect dietary energy or ingredient content.
Vitamin E and evening primrose oil for management of cyclical mastalgia: a randomized pilot study.
Daily doses of 1,200 IU vitamin E, 3,000 mg evening primrose oil, or vitamin E and EPO combined at these dosages for six months may decrease the severity of cyclical mastalgia.
The effects of evening primrose oil on lipid peroxidation induced by subacute aflatoxin exposure in mice.
Evening primrose oil has a positive effect on aflatoxin-induced lipid peroxidation in mice, suggesting its potential as a therapeutic agent for reducing lipid peroxidation in subacute aflatoxin exposure.
DOI